Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation
McLane J. Watson(Vanderbilt University Medical Center), Cindy K. Miranti(University of Arizona)
Cited by 37
Related Papers
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
|Nature Immunology|2022|254
Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase
|Oncotarget|2015|57
An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
|The Journal of Experimental Medicine|2023|44
Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC
|Journal of Cell Science|2017|27